… All 20 patients had evidence of residual disease; the median number of transcripts was 75O/,…
Our findings show that CML has not been eradicated in any patient and that the quantity of …

… -free survival in CML patients treated with nilotinib. A number of different TKIs are now …
The prognostic significance of a candidate variable was assessed with the Wald test. When …

… CML. This lack of information may be due to technical difficulties such as collection and
evaluation of samples in numbers … large number of bone marrow trephines of patients with CML; 2…

… of patient pretreatment clinical and laboratory features was investigated in a group of 303
patients … Intensive chemotherapy was given to 97 patients, and 78 underwent an early elective …

… for binary outcome variables. As survival analyses are using time-to-event variables, a traditional
… However, this can be explained by the smaller number of patients investigated (N=301, …

… a prognostic score for patients receiving HSCT for CML based on five variables: donor type
[… with Revised Risk Scores with a similar outcome to decrease the number of groups to five. …

… The number of people living with this disease has doubled since … CML patients are not
known, 7, 8 and in the current analysis we examine a wide range of potentially relevant variables. …

… CCyR on imatinib is variable: some patients in CCyR show a progressive reduction in the
level of residual disease, some reach a plateau where transcript numbers are relatively stable …

… research on treatments for patients with CML. Our model … CML antigen is present in
proportion to the number of CML cells. … , we first simplify the model by rescaling the variables. …

… strongly correlated to the number of times the patient has to take the medication daily. Most
… Instead of side effects the variable indicating the management of side effects was used as in …